InsidersTradesSigma
Follow the 영진약품 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 영진약품 has recorded 1 public disclosures. Market capitalisation: €209.8bn. The latest transaction was disclosed on 12 March 2026 (Other). Among the most active insiders: 영진약품. Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
영진약품 es una empresa del sector sanitario y farmacéutico, que cotiza en el mercado XKRX. Se especializa en la investigación, desarrollo y fabricación de productos farmacéuticos.